- Home
- BBIO vs FE Comparison
BBIO vs FE Comparison
Compare BBIO & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FE
- Stock Information
- Founded
- BBIO 2015
- FE 1996
- Country
- BBIO United States
- FE United States
- Employees
- BBIO N/A
- FE N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FE Electric Utilities: Central
- Sector
- BBIO Health Care
- FE Utilities
- Exchange
- BBIO Nasdaq
- FE Nasdaq
- Market Cap
- BBIO 6.7B
- FE N/A
- IPO Year
- BBIO 2019
- FE N/A
- Fundamental
- Price
- BBIO $34.48
- FE $42.53
- Analyst Decision
- BBIO Strong Buy
- FE Buy
- Analyst Count
- BBIO 12
- FE 15
- Target Price
- BBIO $57.09
- FE $46.00
- AVG Volume (30 Days)
- BBIO 3.2M
- FE 5.0M
- Earning Date
- BBIO 04-29-2025
- FE 04-23-2025
- Dividend Yield
- BBIO N/A
- FE 4.14%
- EPS Growth
- BBIO N/A
- FE 1.45
- EPS
- BBIO N/A
- FE 1.88
- Revenue
- BBIO $127,415,000.00
- FE $13,764,000,000.00
- Revenue This Year
- BBIO $13.67
- FE $9.24
- Revenue Next Year
- BBIO $118.02
- FE $3.69
- P/E Ratio
- BBIO N/A
- FE $22.84
- Revenue Growth
- BBIO N/A
- FE 8.03
- 52 Week Low
- BBIO $21.62
- FE $37.58
- 52 Week High
- BBIO $39.47
- FE $44.97
- Technical
- Relative Strength Index (RSI)
- BBIO 49.67
- FE 57.47
- Support Level
- BBIO $33.92
- FE $42.38
- Resistance Level
- BBIO $39.16
- FE $43.47
- Average True Range (ATR)
- BBIO 1.43
- FE 0.70
- MACD
- BBIO -0.16
- FE -0.07
- Stochastic Oscillator
- BBIO 31.05
- FE 36.81
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.